capitalstars news update-IHH extends validity of its `Enhanced Revised offer` for Fortis till June 30

Fortis Healthcare (FHL) on Friday said that Malaysia's IHH Healthcare Berhad has extended the validity of its "Enhanced Revised Offer" to invest in the company.

As per a BSE filing, FHL said that its Board has received a letter from IHH for extending the acceptance period for its offer to June 30 from the earlier date of May 29. IHH has proposed to invest directly into the company at Rs 175 per share cost.

"In order to enable the reconstituted Board to fully consider and evaluate our proposal, we now extend the acceptance period of the enhanced revised IHH proposal..." IHH Healthcare Berhad's Managing Director and Group CEO Tan See Leng said in the letter to the Fortis Board.

The development comes just after a consortium of Manipal-TPG had extended the validity of its "modified" new offer till June 6 from the earlier date of May 29.

"We understand that the FHL board is still in the process of considering the modified new offer... in order to provide FHL board with sufficient time to consider our modified new offer, we propose to extend the validity of our modified new offer...," the Manipal Global Health Services said in a letter to the company's Board.

On May 14, the Manipal-TPG consortium had received the "modified" new offer which proposed to values the company at Rs 9,403 crore at a share price of Rs 180 per share.

However, the company's Board on May 10 decided to recommend the offer of the Munjal-Burman consortium for sale of its business to the shareholders for their approval.

Fortis' board had received offers from suitors such as Hero Enterprise Investment Office, Burman Family Office, Fosun Health Holdings, Malaysia's IHH Healthcare Berhad, Manipal Hospital Enterprises and Radiant Life Care for infusion of funds.

In addition, the validity extension of IHH's offer comes as the healthcare major's shareholders voted Director Brian W. Tempest out from the company's Board at the Extraordinary General Meeting (EGM) held on Tuesday. The EGM had sought shareholders approval on a resolution filed by a minority shareholders' group to induct and remove certain Board members among other clearances.

The resolution had sought shareholders approval to replace Tempest, Non-Executive Director Harpal Singh, and Non-Executive Independent Directors Sabina Vaisoha and Tejinder Singh Shergill from the Board.

Harpal Singh, Shergill, and Vaisoha resigned on Sunday citing personal reasons.

visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

Mcx tips,  Intraday stock tips, Financial Advisory Company

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 22 MAY 2018

CS OPENING BELL:

NIFTY SPOT DOWN 14 @ 10502

SENSEX DOWN 35 @ 35575

BANK NIFTY FUTURES DOWN  30 @ 25770

                                                                               HAPPY                                                                                                                        TRADING!!!!!!!!!!!

CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES2: 10690

RES 1:10600

SUP1:10455

SUP2:10365

CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES 2: 26135

RES 1: 26030

SUP1: 25600

SUP2: 25480

visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

Mcx tips, Intraday stock tips 

Financial Advisory company

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 18 MAY 2018

CS OPENING BELL:

NIFTY SPOT DOWN 47 @ 10635

SENSEX DOWN 176 @ 34980

BANK NIFTY FUTURES DOWN  120 @ 25952

                                                                             HAPPY TRADING!!!!!!!!!!!

CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BULLISH

RES2: 10820

RES 1:10750

SUP1:10600

SUP2:10550

CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BULLISH

RES 2: 26310

RES 1: 26185

SUP1: 25830

SUP2: 25740

visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

Mcx tips, Intraday stock tips 

Financial Advisory company

Commodity Tips 

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 16 MAY 2018

CS OPENING BELL:

NIFTY SPOT DOWN 71 @ 1730

SENSEX DOWN 218  @ 35325

BANK NIFTY FUTURES DOWN 207  @ 26035

HAPPY TRADING!!!!!!!!!!!

CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BULLISH

RES2: 10950

RES 1:10800

SUP1:10680

SUP2:10525

CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BULLISH

RES 2: 26570

RES 1: 26430

SUP1: 26300

SUP2: 26000

visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

Mcx tips, Intraday stock tips 

,

Commodity Tips 

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 15 MAY 2018

CS OPENING BELL:

NIFTY SPOT UP 58 @ 10865

SENSEX UP 236  @ 35796

BANK NIFTY FUTURES UP 214  @ 26668

HAPPY TRADING!!!!!!!!!!!

CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES2: 11070

RES 1:10950

SUP1:10770

SUP2:10680

CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES 2: 27005

RES 1: 26950

SUP1: 26304

SUP2: 25935

visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

Mcx tips, Intraday stock tips 

,

Commodity Tips 

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 07 MAY 2018

NIFTY SPOT UP 28 @ 10647

SENSEX UP 107 @ 35023

BANK NIFTY FUTURES UP 80  @ 25782

HAPPY TRADING!!!!!!!!!!!

CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES2: 10800

RES 1:10750

SUP1:10630

SUP2:10570

CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES 2: 25950

RES 1: 25850

SUP1: 25700

SUP2: 25600

visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

Mcx tips, Intraday stock tips 

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS -03 MAY 2018

CS OPENING BELL:

NIFTY SPOT DOWN 35 @ 10683

SENSEX DOWN 96 @ 35078

BANK NIFTY FUTURES DOWN 68 @ 25574

HAPPY TRADING!!!!!!!!!!!

CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES2: 10800

RES 1:10750

SUP1:10650

SUP2:10600

CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH

RES 2: 25755

RES 1: 25680

SUP1: 25550

SUP2: 25450

visit us: www.capitalstars.com/

call on:9977499927

O731-6690000

Get more details here:-

mcx-tips, intraday stock tips  

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: Top Corporate News:- 31 Jan 2018

Top Headlines Of The Day:- 31 Jan 2018

Amber Enterprises up 4% as Kotak fund buys share in company

Workers at Bajaj Auto plants go on indefinite hunger strike, stock opens weak

BEL approves buy-back of 2.04cr equity shares at Rs182.50 per share

NTPC establishes $6bn MTN Programme on India’s International Exchange

SBI hikes bulk deposit rates by 50-140 basis points

Amber Enterprises up 4% as Kotak fund buys share in company
Shares of Amber Enterprises India rose nearly 4% today after Kotak Fund-India Midcap bought 253,290 shares of the company at Rs1, 149.15 in a bulk deal on the NSE.
Shares of Amber Enterprises got listed on Tuesday at a premium of 37% to their issue price of Rs859.
Amber Enterprises India Ltd is currently trading at Rs 1285, up by Rs 47.75 or 3.86% from its previous closing of Rs 1237.25 on the BSE.
The scrip opened at Rs1, 232.5 and has touched a high and low of Rs1, 298.3 and Rs1, 230, respectively. The current market cap of the company is Rs3, 890.72cr.

Workers at Bajaj Auto plants go on indefinite hunger strike, stock opens weak
Workers at Bajaj Auto Limited’s (BJAUT) plants in Akurdi and Chakan have gone on an indefinite hunger strike from January 29, 2018. The workers’ Union involved in this strike is Vishwa Kalyan Kamgar Sanghatana. BJAUT reported this to stock exchanges on January 30, 2018.
The three reason for workers going on hunger strike are i) pending issue of eight workmen dismissed from services for various acts of misconduct in 2013-14, ii) dismissal of six workmen who did not report to place of transfer/deputation despite court orders and iii) delay in conclusion of wage review process due with effect from April 1, 2016. The matter is pending before the Industrial Court, Pune and High Court of Bombay.

BEL approves buy-back of 2.04cr equity shares at Rs182.50 per share
The board of directors of Bharat Electronics Ltd (BEL), in their meeting held on January 30, 2018, approved the proposal to buy-back the equity shares of the company. The buy-back would be of ~2.04cr equity shares (representing 0.83% of total equity shares) at a price of Rs182.50 per share (~7% premium to the last closing price) payable in cash.
The buy-back size amounts to Rs372.26cr, representing 5% of the aggregate of the fully paid-up equity share capital and free reserves of the company. 
The promoter of the company also intends to participate in the proposed buyback. The buyback is subject to approval from the shareholders and all other applicable statutes. The board has fixed February 9, 2018, as the record date for the buy-back.

NTPC establishes $6bn MTN Programme on India’s International Exchange
India’s largest power producer NTPC has listed its $6bn (about Rs40, 000cr) MTN programme (debt instrument) on India International Exchange at IFSC, GIFT City (India INX). While doing so, NTPC became India’s first quasi-sovereign company to list at India INX.
The Listing was done on January 24, 2018, on the Global Securities Market of India INX; India’s first international exchange.
The listing will help NTPC raise funds at lower costs from international investors and also allow foreign investors to access good quality Indian debt paper.

SBI hikes bulk deposit rates by 50-140 basis points
SBI announced that the leading banker is going to increase bulk deposit rates by 50-140 bps effective today. Following this announcement, shares of SBI reached a high of Rs318.8 in the morning trade, gaining ~2%. However, the stock was unable to hold on to the gains as the day progressed.
The stock ended at Rs312.85, up by Rs1.75 or 0.56% from its previous closing of Rs311.1 on the BSE. The scrip opened at Rs311.05 and has touched a high and low of Rs318.75 and Rs310.8 respectively.
The bank’s FY17 consolidated loan book stood at Rs.19.5 lakh cr. Its consolidated GNPA & NNPA stood at 9.1% & 5.2% as of FY17.

MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: Top Corporate News :- 30 Jan 2018

Top Headlines Of The Day:- 30 Jan 2018

Jubilant receives ANDA approval for Clonidine Hydrochloride ER Tablets

KPIT and Birlasoft to come together to create two entities

Mylan and Biocon receive positive CHMP opinion for Insulin Glargine

Amber Enterprises lists at 38% premium to issue price

HCL Tech gets 5-year order from Cadent for IT Infra services

Jubilant receives ANDA approval for Clonidine Hydrochloride ER Tablets
Jubilant Life Sciences has announced that its material wholly owned subsidiary Jubilant Pharma Limited has received Abbreviated New Drug Application (ANDA) final approval for Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg. This is a generic version of Kapvay of Concordia. It is used for the treatment of attention deficit hyperactivity disorder (ADHD).
As on December 31, 2017, Jubilant had a total of 86 ANDAs for Oral Solids filed in the US of which 56 had been approved and 12 Injectable filings of which 10 had been approved. This is the eighth USFDA approval in FY18.

Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg had annual sales of ~USD 66 million in the US as per IMS MAT Jun 2017. 

KPIT and Birlasoft to come together to create two entities
KPIT Technologies had informed the exchanges that its board had approved a draft composite scheme for amalgamation of Birlasoft (India) with KPIT. The second leg of the transaction would involve demerger of the engineering business of the company into KPIT Engineering Limited (KEL), a wholly owned subsidiary of the company and will be renamed as KPIT Technologies Limited.
According to the arrangement, shareholders of Birlasoft will receive 22 equity shares of the combined KPIT -Birlasoft for every nine equity shares of Birlasoft. the combined KPIT-Birlasoft will be engaged in the ITSS Business, and pursuant to the Proposed Demerger, KEL's shares will be listed and shareholders of combined KPIT-Birlasoft will receive one share of KEL for each share they hold in the combined KPIT-Birlasoft.

Mylan and Biocon receive positive CHMP opinion for Insulin Glargine
Biocon has announced that it, along with its partner Mylan, has received a positive opinion from Europen Medical Agency’s (EMA) - Committee for Medicinal Products for Human Use (CHMP) - for insulin Glargine. CHMP has also recommended approval to Insulin Glargine, which will be sold under brand Semglee.
There are ~60m people affected by diabetes in Europe with an increasing prevalence in the region. Insulin Glargine is a biosimilar, which will be available for commercialization once it receives EMA approval.
Biocon and Mylan are also awaiting approval for Insulin Glargine in Australia, Canada, and the US and are planned for key Emerging Markets.

Amber Enterprises lists at 38% premium to issue price
Amber Enterprises listed at a significant premium of 38% to its issue price of Rs855-859 and is currently trading at Rs1, 187.2.
The IPO offer consisted of Fresh Issue of 55.3 lakh shares (aggregating up to ~Rs475cr) at the upper end of the price band. It also includes an offer for sale of up to 14.6 lakh shares (Rs125cr) by the promoters. The issue proceeds will be used for pre-payment or repayment of borrowings (~Rs400cr) and for other general corporate purposes (~Rs75cr).

HCL Tech gets 5-year order from Cadent for IT Infra services
HCL Technologies (HCL) announced a five-year IT infrastructure services and application management contract with Cadent, the UK’s largest gas distribution network. The ground-breaking ‘cloud first’ multi-service deal will see HCL provide integrated public cloud hosting and SAP and Application Maintenance Services, including the migration of a significant applications portfolio to Amazon Web Services (AWS) public cloud. In addition, HCL will provide IT Service Management, Service Desk and Managed Workplace Services.
HCL will deliver these services to support Cadent’s business operations which distributes gas to 11 million homes and businesses in the North West, Midlands, East and South East of England. HCL will provide MWS support to approximately 4,500 staff; including 3,500 field based-engineers who work across the company’s 65 regional depots.

MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: Top Corporate News :- 29 Jan 2018

Top Headlines Of The Day :- 29 Jan 2018

Avenue Supermarts Ltd (DMart), up 5% after announcing Q3FY18 results, PAT up 65.8% yoy
Cipla, Aurobindo and Strides Shasun receive final approval for gViread
Havells to set up a manufacturing unit in Rajasthan for an investment of Rs360cr
DLF is looking to launch QIP of shares by April, 2018
Idea Cellular seeks government approval for raising FDI limit to 100%

Avenue Supermarts Ltd (DMart), up 5% after announcing Q3FY18 results, PAT up 65.8% yoy
DMart rallies 5% after announcing Q3FY18 results. In Q3FY18, its revenue grew by 22.6% yoy to Rs4, 095cr. EBITDA came in at Rs422cr, up 46.3% yoy . EBITDA margin expanded by 167bps yoy to 12.3% due to an improvement in sales mix and efficiency of centralized procurement. Adjusted PAT increased by 65.8% yoy to Rs252cr.
Board has also approved acquisition of 50.8% paid-up share capital of Avenue E-Commerce Limited for Rs49.2cr. Post-acquisition it will become wholly owned subsidiary. Heavy discounts to attract price sensitive customers and losses of the e-commerce entity will offset the margin gains.

Cipla, Aurobindo and Strides Shasun receive final approval for gViread
Cipla, Aurobindo and Strides Shasun have received final approval for their Abbreviated New Drug Application (ANDA) for Tenofovir Disoproxil Fumarate Tablets, 300mg, from the USFDA. This is a generic version of Gilead Sciences' Viread Tablets, 300mg which is indicated in combination with other antiretroviral (ARV) agents for the treatment of HIV-1 infection in adults. The final approval means that product is available for immediate commercialization in the US.
Viread 300mg tablets had annual US sales of approximately $725-750mn as per IMS Health. An orange book search on USFDA website indicates that Aurobindo, Cipla, Teva, Macleods Pharmaceuticals and Strides Shasun, all have received approval for this drug on January 26, 2018. Approval for five different filers on the same day is likely to see competition for the Viread 300mg tablets.

Havells to set up a manufacturing unit in Rajasthan for an investment of Rs360cr
Havells is setting-up a new facility at Ghiloth, Neemrana, Rajasthan to manufacture consumer durables, as per the BSE filing. The total estimated cost for the project is Rs360cr (ex-land cost, as the company already owns the land), spread over a period of 3 years. The total investment will be funded through a mix of internal accruals and borrowings. Company expects to start the production from Q3FY19E.
For this investment, the company will be entitled to investment subsidy under the M-SIPS (Modified Special Incentive Package Scheme) introduced by MEITY and also for various tax/ levies and other benefits from the State Government of Rajasthan.

DLF is looking to launch QIP of shares by April, 2018
DLF is looking to launch its qualified institutional placement (QIP) of shares by April 2018, according to a media report.
DLF has already received approval from shareholders to sell 173-million equity shares, which will be determined by the formula laid down by the market regulator Securities and Exchange Board of India. The company may raise Rs4500-5000cr from the QIP.

Idea Cellular seeks government approval for raising FDI limit to 100%
Telecom operator Idea Cellular has made an application to the DIPP (Department of Industrial Policy and Promotion) for raising the FDI limit in Idea to 100%. Foreign investors holdings in Idea Cellular stood at ~27% stake as on December 2017. While 100% FDI is allowed in telecom companies, investments under the automatic route are allowed up to 49%.
At present, Idea Cellular is in the process of merging its telecom business with the Indian unit of Vodafone. As per latest industry data from Trai, Idea and Vodafone jointly have 40.5cr mobile subscribers. This would potentially give the joint entity the largest subscriber base in the Indian telecom segment. Vodafone is expected to hold around 47.5% stake in the merged entity and rest will be owned by Idea and its promoter Aditya Birla Group.

MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Capitalstars Updates: News that mattered during the week: 20 Jan 2018

Important news that made headlines during the week.

• Biocon enters into a global partnership with Sandoz to develop, manufacture and commercialize multiple biosimilars in immunology and oncology
• Torrent Pharma acquires US-based generic pharmaceuticals Bio-Pharma Inc
• Tech Mahindra to acquire 17.5% shares of Altiostar on a fully diluted basis
• TCS expands partnership with Shure Inc to establish global development center
• Housing Finance gets RBI nod for US $500mn masala bonds
• Adani Power gets 49% stake in 600 MW Korba West Power
• Varun Beverages to acquire franchisee rights for Pepsico India in the state of Bihar
• Sun Pharma got a license to sell the generic version of Linzess in the US from February 1, 2031, after settling patent litigation
• GAIL, Gazprom sign pact for re-negotiated long-term LNG sale
• Texmaco Rail considering setting up logistics hub and food park in West Bengal
• Kotak Mahindra is mulling divesting its stake in MCX
• Bajaj Finance to hold 12.6% stake in Mobikwik on a fully diluted basis post-conversion of Compulsorily Convertible Preference Shares for a total investment of Rs225cr

MCX Tips,  Intraday Stock Tips ,  Equity Tips  , Free Trading Tips , Sebi Regsitred Advisory Company , Capitalstars Video Gallery

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

CapitalStars Market Ad On CNBC Awaaz, Pehla Kadam Date 18 Dec 2017

CapitalStars Market Ad On CNBC Awaaz, Pehla Kadam Date 18 Dec 2017

CapitalStars Award Winning, SEBI registered, ISO certified investment advisory company. We provide intraday & positional services in equity , derivative ,commodity & currency. Our research team is highly skilled & experienced please contact 0731-6690000.

Visit Our Site- http://capitalstars.com/video-gallery

CLICK HERE FOR GET DETAILS & JOIN OUR BEST ADVISORY  -

 CAPITALSTARS CALL US  9977499927

Equity Tips , Intraday Stock Tips , FreeTrading Tips  , Sebi Registered advisory Company , Capitalstars Video Gallery

Investment  & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647